Yoshiro Nakahara

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study

Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara et al. · Clinical Lung Cancer · 2018 · 106 citations

Prognostic Biomarkers, Cancer Immunosurveillance, Lung Inflammation +9

Low-Dose Erlotinib Treatment in Elderly or Frail Patients With <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer

Shingo Miyamoto, Koichi Azuma, Hidenobu Ishii et al. · JAMA Oncology · 2020 · 46 citations · Full text

Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing

Shuji Murakami, Tomoyuki Yokose, Daiji Nemoto et al. · Diagnostics · 2021 · 40 citations · Full text

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA

Thomas John, Hiroshi Sakai, Satoshi Ikeda et al. · International Journal of Clinical Oncology · 2022 · 32 citations · Full text

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · Cancer Management and Research · 2018 · 28 citations · Full text